
from
TF Market Research29 page report
published Jan 29, 2007
Price
$1,160.00 available for immediate download

This report is also available for purchase on a
per-page basis.
Report Overview
Purchase by Section
Search Inside
...Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic pharmaceuticals in ophthalmology, rheumatology, anesthesia, and antidotes areas primarily in the United States. It operates through three segments: Ophthalmic, Injectable, and Contract Services. The Ophthalmic Segment manufactures and markets a line of diagnostic and therapeutic ophthalmic pharmaceutical products. Its diagnostic products include mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes. The segment s therapeutic products include antibiotics, anti -infectives, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti -edema medications. This segment s nonpharmaceutical products include various artificial tear solutions, preservative-free lubricating ointments, eyelid cleansers, vitamin supplements, and contact lens accessories. The Injectable Segment engages in the manufacture and marketing of a line...
Source: LIFE SCIENCE ANALYTICS
Company: AKORN INC
Geographic Regions: ILLINOIS (STATE OF), MIDWEST/MIDWESTERN REGION, NORTH AMERICA, UNITED STATES OF AMERICA
TF Market ResearchTF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.